WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-55 Cr | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr | ₹-217 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-55 Cr |
Mar2023 | ₹-198 Cr |
Mar2022 | ₹-189 Cr |
Mar2021 | ₹-258 Cr |
Mar2020 | ₹-217 Cr |
How is Net Current Assets of WANBURY Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-55 Cr | Negative | |
Mar2023 | ₹-198 Cr | Negative | |
Mar2022 | ₹-189 Cr | Negative | |
Mar2021 | ₹-258 Cr | Negative | |
Mar2020 | ₹-217 Cr | - |
Compare Net Current Assets of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹824.6 Cr | -2.7% | -9.5% | 24.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -2.7% |
-9.5% |
24.4% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses